osteoporosis
OSTEOPOROSIS
Osteoporosis is the progressive, systemic skeletal disease characterized by decreased bone mass and micro-architectural deterioration of bone tissue leading to bone fragility and increased susceptibility to fractures.
The more risk factors (eg history, of fracture, advanced age, comorbidities, impaired vision) that are present, the greater the risk of fracture.

Definition

  • Progressive, systemic skeletal disease characterized by decreased bone mass & micro-architectural deterioration of bone tissue leading to bone fragility & increased susceptibility to fractures
    • Bone strength, reflecting both density & quality of the bone, is compromised thus increasing fracture risk
    • Fractures commonly occur in the hip, spine & wrist with the hip fractures having a high morbidity
  • Common presentations: Back pain, low-trauma fracture, height loss, increasing dorsal kyphosis

Risk Factors

Risk Factors in Women for Fracture & Osteoporosis
The more risk factors that are present, the greater the risk of fracture
Non-modifiable
  • Previous history of fracture as an adult
  • History of osteoporotic hip fracture in 1st-degree relative
  • Advanced age [low body weight & older age (Osteoporosis Self-Assessment Tool for Asians - OSTA)]
  • Poor health/frailty
  • Ethnic group (Asians generally have lower risk compared to Caucasians)
  • Early natural or surgical menopause before 45 year of age or prolonged premenopausal amenorrhea >1 year
  • Genetic diseases: Cystic fibrosis, osteogenesis imperfecta, Ehlers-Danlos, hemochromatosis, Marfan syndrome
Modifiable
  • Recurrent falls
  • Decreased body weight (<57.6 kg [<127 lbs])
  • Impaired vision
  • Medical conditions: Rheumatoid arthritis, estrogen deficiency, Vitamin D deficiency due to lack of sunlight exposure or low intake, thyrotoxicosis, or prolonged Levothyroxine intake
  • Cigarette smoking
  • Excessive alcohol (≥3 drinks/day) & caffeine intake
  • Low calcium (Ca) intake, excessive salt intake
  • Excessive Vitamin A intake
  • Oral glucocorticoid use ≥5 mg/day of prednisone for ≥3 month
  • Sedentary lifestyle (lack of physical activity)
  • Secondary osteoporosis
Risk Factors in Men for Fracture & Osteoporosis
  • Non-traumatic fractures of the hip, vertebrae or wrist
  • Prior osteoporotic fracture from age 50 years
  • Hypogonadism, growth hormone deficiency
  • Idiopathic hypercalciuria
  • Hyperparathyroidism
  • Rheumatoid arthritis
  • Lymphoma, multiple myeloma
  • Hyperthyroidism
  • Oral glucocorticoid use ≥5 mg/day of prednisone for ≥3 month
  • Physical inactivity
  • Low body mass index (kg/m2)
  • Anticonvulsants (eg Phenytoin, Phenobarbital)
  • Smoking
  • Alcohol intake (≥3 drinks/day)

Factors Associated with Glucocorticoid-Induced Osteoporosis (GIOP) or Fractures

  • Low bone density
  • Cumulative steroid dose
  • Age >65 years
  • BMI ≤20 kg/m2
  • Smoking, excessive alcohol use
  • Diseases associated with low bone density (eg rheumatoid arthritis, inflammatory bowel disease), sex hormone deficiency, family history of osteoporosis, history of fracture & immobilization
Editor's Recommendations
Most Read Articles
4 months ago
Erectile dysfunction may potentially be associated with gout, a new systematic report and meta-analysis reveals. However, the low quality and high degree of heterogeneity among the studies included reduce the certainty of this conclusion.
5 days ago
Patients with juvenile-onset systemic lupus erythematosus (jSLE) have a higher frequency of renal involvement, cutaneous symptoms, oral ulcers, neuropsychiatric (NP) manifestations, autoimmune hemolytic anaemia (AIHA) and anti-dsDNA positivity than those with adult-onset SLE (aSLE), a recent study has found.
one month ago
At the International Osteoporosis Foundation Regionals – 6th Asia-Pacific Osteoporosis Meeting in Singapore, Professor Olivier Bruyère shared about the algorithm for the management of knee OA by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). MIMS Doctor also spoke to Professor Jean-Yves Reginster, president of ESCEO about this algorithm and the role of SYSADOAs in the control of pain and prevention of disease progression.
one month ago
The goal of this module is to provide an overview on ankylosing spondylitis. Click here to learn more.